Recap: Applied DNA Sciences Q3 Earnings

Shares of Applied DNA Sciences APDN fell 7.8% in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share rose 36.11% year over year to ($0.46), which missed the estimate of ($0.22).

Revenue of $1,700,000 rose by 293.96% year over year, which missed the estimate of $3,130,000.

Looking Ahead

Applied DNA Sciences hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

Conference Call Details

Date: Aug 12, 2021

Time: 04:30 PM

ET Webcast URL: https://services.choruscall.com/mediaframe/webcast.html?webcastid=Bin1qa3n

Price Action

Company's 52-week high was at $13.64

52-week low: $4.95

Price action over last quarter: down 1.78%

Company Overview

Applied DNA Sciences Inc is a provider of DNA-based supply chain, anti-counterfeiting, and anti-theft technology. The company provides its products and services under the brand of SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. It serves clients in various industries including government/military, security and asset marking, industrial parts, pharmaceuticals, textiles and apparel, and printing and packaging. The company has operational footprints across the United States, Europe, Asia, and others.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!